Navigation Links
Medrio, a Leading EDC Provider for Clinical Research, Announces eClinical Networking and Dinner Seminar
Date:10/2/2013

San Francisco, CA (PRWEB) October 02, 2013

Medrio, a leading provider of Electronic Data Capture and eClinical tools, announced they will be hosting their first annual eClinical Networking and Dinner Seminar in partnership with Peter Shabe, CEO and President of Advance Research Associates, on October 17th, 2013.

“I’m excited to announce our first eClinical Dinner Seminar, featuring Peter Shabe of Advance Research Associates who will be sharing best practices and expertise on the Role of Statistics in Clinical Trials,” said Scott Weidley, Sr. Senior Director of Sales and Marketing. “Medrio strives to provide valuable resources to the clinical research community and I’m looking forward to hosting this event.”

The role of statistics in a clinical trial provides a structured process to quantify the safety and efficacy of an investigational product and compare one to another with a reliable and reproducible result.

Peter will provide a brief, concise, and entertaining overview of statistics by guiding us through four basic steps: 1) collecting data, 2) summarizing data, 3) performing statistical analysis of results, and 4) learning how to generalize results to the population being studied.

About Medrio
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit http://www.medrio.com.

About Peter Shabe
Peter Shabe has over 25 years of experience in Phase I - IV clinical trials of drug and medical device development. His expertise includes SAS for developing data management and data analysis applications, as well as analyzing and reporting clinical data.

In 1996, Peter founded his own company, Advance Research Associates, where he manages a team of bio statisticians and data management professionals for clients worldwide. For more information, visit http://www.advanceresearch.com.

Read the full story at http://www.prweb.com/releases/eClinicalsoftware/eClinicaltools/prweb11185447.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Independent Research Shows That Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Continues to Achieve Exceptional Scores in Customer Satisfaction
2. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
3. Diabetes drug could treat leading cause of blindness
4. Pneumonia and preterm birth complications are the leading causes of childhood death
5. Leading health care quality expert is 2012 AcademyHealth Distinguished Investigator
6. Dr. Edmund Lipskis & Dr. Lynn Lipskis Will be Featured On New National Television Show Entitled: “Leading The Field” World Class Experts Share Their Tips & Advice
7. ACR: Medical imaging study in health affairs incomplete and potentially misleading
8. Poorly-performing hand implants unacceptable says leading medical journal
9. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
10. WSU researchers discover mechanism leading from trichomoniasis to prostate cancer
11. Report: Cancer now leading cause of death in US hispanics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , ... February 05, 2016 , ... ... setting the stage for new clinical and scientific initiatives have all marked the ... she was appointed President and CEO of the nation’s oldest cancer center, Candace ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... College President George H. Van Allen have signed a joint enrollment and degree ... a seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , The ...
(Date:2/5/2016)... ... 05, 2016 , ... The American public tends to feel uncomfortable about drinking ... regular municipal or well water. The recent experience with lead contaminated water in Flint, ... long way toward increasing public acceptance of recycled waste water as drinking water. ...
(Date:2/5/2016)... ... 05, 2016 , ... At its annual meeting held last week, the American ... National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We ... Chambers , APDA President and CEO. “Pat has tirelessly served APDA since 2001 when ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of the day ... feature of patients with eating disorders is significant self-criticism, and consequently these patients experience ... are regarded as maladaptive means for coping with this unease, but also leads to ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... CENTENNIAL, Colo. , Feb. 5, 2016  As ... about health. The multitude of recommended screenings and tests ... healthy aging a priority. However, for the majority of ... of proactive health planning. For the 37.5 million American ... time like the present to make hearing health a ...
(Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
(Date:2/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... underwritten secondary offering of 11,027,558 shares of its common ... of Blackstone and Goldman Sachs.  The shares are being ... $96.45 per share. The selling stockholders will receive all ... nor any of its directors, officers or other stockholders ...
Breaking Medicine Technology: